TrianglePUBLICATIONS · 35441128
Long-term Outcomes With Ibrutinib Treatment for Patients With Relapsed/Refractory Mantle Cell Lymphoma: A Pooled Analysis of 3 Clinical Trials With Nearly 10 Years of Follow-up.
Open original source → · Download preserved record
Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.
- Journal
- Hemasphere
- Publication date
- 2022 May
- First author
- Dreyling M
Publication notices
- absence is not clearance
- true
- has correction metadata
- false
- has expression of concern metadata
- false
- has retraction in link
- false
- pubmed marks article retracted
- false
- pubmed marks retraction notice
- false
- relationships
Authors and identifiers
- name
- Dreyling M
- type
- Author
- name
- Goy A
- type
- Author
- name
- Hess G
- type
- Author
- name
- Kahl BS
- type
- Author
- name
- Hernández-Rivas JÁ
- type
- Author
- name
- Schuier N
- type
- Author
- name
- Qi K
- type
- Author
- name
- Deshpande S
- type
- Author
- name
- Zhu A
- type
- Author
- name
- Parisi L
- type
- Author
- name
- Wang ML
- type
- Author
Complete bibliographic record and source provenance
- authors
- name
- Dreyling M
- type
- Author
- name
- Goy A
- type
- Author
- name
- Hess G
- type
- Author
- name
- Kahl BS
- type
- Author
- name
- Hernández-Rivas JÁ
- type
- Author
- name
- Schuier N
- type
- Author
- name
- Qi K
- type
- Author
- name
- Deshpande S
- type
- Author
- name
- Zhu A
- type
- Author
- name
- Parisi L
- type
- Author
- name
- Wang ML
- type
- Author
- bibliography ids
- nci-bib-4dc34a6ddbba16232e90c583
- book metadata
- content sha256
- a01086f5c9b133aab5dc7fe3559b0d2dff92fc22f53166db771dc82bf5e870a0
- document type
- citation
- dois
- 10.1097/HS9.0000000000000712
- electronic publication date
- display
- 2022 Apr 13
- precision
- day
- year
- 2022
- evidence scope
- bibliographic_metadata_only
- id
- pubmed:35441128
- immutable id
- pubmed:35441128@a01086f5c9b133aab5dc7fe3559b0d2dff92fc22f53166db771dc82bf5e870a0
- journal
- abbreviation
- Hemasphere
- issn electronic
- 2572-9241
- issn print
- Source null
- issue
- 5
- name
- HemaSphere
- nlm unique id
- 101740619
- pages
- e712
- volume
- 6
- languages
- eng
- notices
- absence is not clearance
- true
- has correction metadata
- false
- has expression of concern metadata
- false
- has retraction in link
- false
- pubmed marks article retracted
- false
- pubmed marks retraction notice
- false
- relationships
- outcomes validated
- false
- pmid
- 35441128
- provenance
- batch id
- 9d150d55960e0c12aada
- provider
- NCBI PubMed ESummary
- record sha256
- eba8bca216a6237322c37080378fe6a3db8a932e32b4311e35c2b4e8a8c09c12
- response sha256
- 2d4ef1cc8137eef6e7216f66bf8601c3899bc663b8626f412794d39585de6b6b
- retrieved at
- 2026-09-09T23:48:09.820498+00:00
- publication date
- display
- 2022 May
- precision
- month
- year
- 2022
- publication types
- Journal Article
- record status
- PubMed
- schema version
- 1.0
- title
- Long-term Outcomes With Ibrutinib Treatment for Patients With Relapsed/Refractory Mantle Cell Lymphoma: A Pooled Analysis of 3 Clinical Trials With Nearly 10 Years of Follow-up.
Preserved source evidence · Not medical advice